Access to the PDF text

Free Article !

Archives of cardiovascular diseases
Volume 102, n° S1
page 43 (mars 2009)
Doi : 10.1016/S1875-2136(09)72229-6
Themes et posters

D019 Context-dependent modulation of cell extravasation from blood vessels by ANGPTL4

M. Durand 1, E. Gomez 1, A. Cazes 1, M. Lesage 1, J. Philippe 1, A. Galaup 1, S. Germain 1, 2
1 Inserm U833 – Collège de France, Paris, France 
2 Service d’Hématologie Biologique A, Hôpital Européen Georges Pompidou, AP-HP, Paris, France 


Angiopoietin-like 4 (ANGPTL4), a secreted protein of the angiopoietin-like family, is induced by hypoxia in both tumor and endothelial cells. It is highly expressed in tumor cells from conventional renal carcinoma and in hypoxic perinecrotic areas of numerous types of human tumors (1).

We previously showed that ANGPTL4, through its action on both vascular and tumor cells, prevents metastastes through inhibition of vascular permeability as well as tumor cell motility and invasiveness. In vivo, using both Lewis Lung carcinoma cells as well as melanoma B16 cells, we showed ANGPTL4 inhibits both intravasation extravasation of tumor cells. Using Miles assay, ANGPTL4 inhibited the histamine-induced vascular permeability in electrotransferred mice overexpressing ANGPTL4 compared to control mice (2).

More recently, Padua et al. revealed a clinical association between TGFbeta activity in primary tumors and risk of distant recurrence, specifically for estrogen receptor negative breast tumors with lung metastasis but not bone metastasis. In vivo, lung metastasis seeding from mammary tumors depends on TGFbeta receptors, Smad function and ANGPTL4 expression (3).

Both groups therefore report ANGPTL4 as a key regulator of vascular permeability. Nevertheless, better insights are needed in order to precisely characterize its role during tumor angiogenesis and subsequent metastases in various organs, namely lungs and bones. The aim of the present study is to address the in vivo role of ANGPTL4 in modulating vascular integrity, using Lewis Lung carcinoma cells xenografted in ANGPTL4 KO mice. Inhibition of tumor growth is observed in KO mice compared to WT mice (1207+/-105 mm3 versus 3053+/-569 mm3 at day 26, p=0.002). At day 33, 60 % of the angptl4 KO mice show large lung macrometastases whereas only 28 % of wild type lungs have been invaded by small micrometastases.

Further experiments using different metastatic models are ongoing in order to perform imaging analysis of blood vessels and endothelium integrity the during the metastatic process in angptl4 knock-out and WT mice.1. Le Jan, S. (2003) Am J Pathol 162, 1521-8 .2. Galaup, A. (2006) Proc Natl Acad Sci U S A 103, 18721-6 .3. Padua, D. (2008) Cell 133, 66-77 .

The full text of this article is available in PDF format.
The full text of this article is available in PDF format.
Click here to see it.

Top of the page

© 2009  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline